As of Nov 19, 2026, 1 of 1 active firms rate TLSA a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
TLSA EPS & revenue forecast
EPS · NEXT QUARTER
$0.00
Range $0.00 – $0.00 · 0 analysts
Next period, 0 analysts expect Tiziana Life Sciences Ltd to earn $0.00 a share (range $0.00 – $0.00), versus — a year earlier. Full-year consensus is $-0.13, growing to $-0.14 the year after.
REVENUE · NEXT QUARTER
—
Range — – — · 0 analysts
Revenue is expected to reach — (range — – —). Full-year consensus is $0, rising to $0 next year.
Top analysts covering Tiziana Life Sciences Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TLSA.
#1
Thomas Shrader
BTIG · Rank #553
Buy
$7.00+765.9% to target
Overall win rate
32%
+ Follow
#2
Elemer Piros
Lucid Capital
Buy
$8.00+889.6% to target
Coverage
—
+ Follow
TLSA stock forecast FAQ
What is TLSA's average 12-month price target?+
The 1 active firms with a live target average $7.00 for Tiziana Life Sciences Ltd over the next 12 months, ranging from a $7.00 high to a $7.00 low, as of Nov 19, 2026.
Is TLSA stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 1 active firms as of Nov 19, 2026, 1 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover TLSA?+
1 active firms have a recognized rating on Tiziana Life Sciences Ltd as of Nov 19, 2026, and 1 active firms carry a live 12-month price target.
Who is the most accurate analyst covering TLSA?+
Among analysts who currently cover TLSA, Thomas Shrader of BTIG has the strongest overall Quantellect track record (Rank #553). Their current call is Buy with a $7.00 target.
What is Tiziana Life Sciences Ltd's projected EPS for next quarter?+
The consensus estimate is $0.00 per share (range $0.00 – $0.00) across 0 analysts. Full-year EPS is projected at $-0.13, rising to $-0.14 the following year.
How much revenue is Tiziana Life Sciences Ltd expected to report next quarter?+
Consensus revenue is — (range — – —). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading TLSA lately?+
As of Nov 19, 2026, 1 of 1 active firms rate TLSA a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TLSA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.